home All News open_in_new Full Article
AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q2 2025 OF $13,363,509
Ayurcann Holdings Corp. reported record sales growth of $13,363,509 for Q2 2025, representing a 25% increase year-over-year. The company achieved a 43% gross margin and positive adjusted EBITDA of $815,085, reflecting strong profitability. As a top producer of vapes in Ontario, Ayurcann is well-positioned for continued growth, with plans to exceed $50 million in revenue and maintain positive EBITDA in 2025. The company’s diverse product portfolio, including vapes, pre-rolls, and concentrates, supports its leadership in the Canadian cannabis market.
For more information, contact Igal Sudman, CEO, at 905-492-3322 or visit www.ayurcann.com.
today 8 h. ago attach_file Economics
attach_file
Economics
attach_file
Sport
attach_file
Sport
attach_file
Politics
attach_file
Sport
attach_file
Economics
attach_file
Other
attach_file
Events
ID: 1705705156